Nelson Vergel
Founder, ExcelMale.com
Researchers have published a study in Lancet Infectious Diseases showing encouraging results of an in-human study for a chlamydia vaccine, the first in the world to advance this far. If the vaccine continues to be effective through later-stage studies, it could become an important public-health tool against the most common sexually transmitted bacterial infection in the world.
The First In-Human Chlamydia Vaccine Trial Shows Positive Immune Response | TheBodyPro
The First In-Human Chlamydia Vaccine Trial Shows Positive Immune Response | TheBodyPro